بدائل البحث:
significant effect » significant impact (توسيع البحث)
effect decrease » effects decreased (توسيع البحث)
lower decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), teer decrease (توسيع البحث)
significant effect » significant impact (توسيع البحث)
effect decrease » effects decreased (توسيع البحث)
lower decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), teer decrease (توسيع البحث)
-
141
-
142
-
143
-
144
-
145
Key safety measures including adverse events.
منشور في 2025"…Waist circumference (mean change (MC) −2.23 cm; 95% CI [−3.98, −0.49]; <i>p</i> = 0.01), BMI (MC −0.49 kg/m<sup>2</sup>; 95% CI [−0.88, −0.10[; <i>p</i> = 0.01), and android fat mass measured by DXA (MC −167 g; 95% CI [−264, −71[; <i>p</i> < 0.001) decreased in the COCP group over the study period whilst there was no statistically significant changes in these parameters in the metformin only group when compared to baseline.. …"
-
146
-
147
-
148
-
149
Risk of bias across 22 included studie.
منشور في 2024"…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …"
-
150
An overview of the selection process for studies.
منشور في 2024"…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …"
-
151
Characteristics of studies (<i>n</i> = 22).
منشور في 2024"…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …"
-
152
-
153
-
154
Multiple comparisons after ANOVA(CR10).
منشور في 2025"…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …"
-
155
Homogeneity test of CR10.
منشور في 2025"…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …"
-
156
Illustration of the fNIRS device worn.
منشور في 2025"…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …"
-
157
Analysis of variance of HbO<sub>2</sub> in bilateral PFC.
منشور في 2025"…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …"
-
158
fNIRS equipment coordinates.
منشور في 2025"…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …"
-
159
Changes of muscle oxygen saturation.
منشور في 2025"…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …"
-
160
Analysis of variance of CR10.
منشور في 2025"…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …"